JPMORGAN CHASE & CO - INVIVO THERAPEUTICS HLDGS CO ownership

Back to all holdings Add to watchlist

INVIVO THERAPEUTICS HLDGS CO's ticker is NVIV and the CUSIP is 46186M209. A total of 2 filers reported holding INVIVO THERAPEUTICS HLDGS CO in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of INVIVO THERAPEUTICS HLDGS CO
ValueSharesWeighting
Q1 2018$0–739–0.00%–
 Download
Other shareholders

There were no reported owners of INVIVO THERAPEUTICS HLDGS CO in Q2 2018.

NameSharesValueWeighting ↓
View complete list of INVIVO THERAPEUTICS HLDGS CO shareholders